| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Bead-based multiplex genotyping of human papillomaviruses.
|
J Clin Microbiol
|
2006
|
3.13
|
|
2
|
Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer.
|
J Clin Oncol
|
2013
|
2.87
|
|
3
|
Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin.
|
J Natl Cancer Inst
|
2006
|
2.40
|
|
4
|
Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers.
|
J Clin Microbiol
|
2008
|
1.90
|
|
5
|
Biomarkers of HPV in head and neck squamous cell carcinoma.
|
Cancer Res
|
2012
|
1.76
|
|
6
|
Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions.
|
Int J Epidemiol
|
2011
|
1.55
|
|
7
|
Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay.
|
J Clin Microbiol
|
2009
|
1.55
|
|
8
|
Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma.
|
J Clin Oncol
|
2007
|
1.53
|
|
9
|
Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.45
|
|
10
|
Neuromyelitis optica following human papillomavirus vaccination.
|
Neurology
|
2012
|
1.44
|
|
11
|
Seroprevalence of 34 human papillomavirus types in the German general population.
|
PLoS Pathog
|
2008
|
1.44
|
|
12
|
Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types.
|
J Gen Virol
|
2008
|
1.35
|
|
13
|
Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma.
|
Cancer Res
|
2010
|
1.30
|
|
14
|
Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.29
|
|
15
|
Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
|
J Natl Cancer Inst
|
2013
|
1.29
|
|
16
|
Helicobacter pylori multiplex serology.
|
Helicobacter
|
2009
|
1.29
|
|
17
|
A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition.
|
Int J Cancer
|
2007
|
1.22
|
|
18
|
Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study.
|
BMJ
|
2010
|
1.18
|
|
19
|
Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians.
|
J Gen Virol
|
2010
|
1.16
|
|
20
|
Global hypomethylation identifies Loci targeted for hypermethylation in head and neck cancer.
|
Clin Cancer Res
|
2011
|
1.15
|
|
21
|
Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.12
|
|
22
|
InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers.
|
J Natl Cancer Inst
|
2012
|
1.09
|
|
23
|
Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples.
|
Int J Cancer
|
2007
|
1.07
|
|
24
|
Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor.
|
Oncol Rep
|
2013
|
1.06
|
|
25
|
Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.
|
Int J Cancer
|
2008
|
1.05
|
|
26
|
Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns.
|
Cancer Res
|
2009
|
1.05
|
|
27
|
Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.04
|
|
28
|
Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer.
|
Am J Epidemiol
|
2012
|
1.04
|
|
29
|
Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.02
|
|
30
|
High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis.
|
J Invest Dermatol
|
2008
|
1.02
|
|
31
|
Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy.
|
J Gen Virol
|
2009
|
1.01
|
|
32
|
Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue.
|
J Clin Microbiol
|
2005
|
0.97
|
|
33
|
Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients.
|
Med Microbiol Immunol
|
2011
|
0.96
|
|
34
|
Seroepidemiology of Human Polyomaviruses in a US Population.
|
Am J Epidemiol
|
2015
|
0.96
|
|
35
|
HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker?
|
Cancer Lett
|
2012
|
0.95
|
|
36
|
Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study.
|
Int J Cancer
|
2008
|
0.95
|
|
37
|
Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort.
|
Int J Cancer
|
2014
|
0.94
|
|
38
|
Regression of cutaneous warts in a patient with WILD syndrome following recombinant quadrivalent human papillomavirus vaccination.
|
Arch Dermatol
|
2010
|
0.93
|
|
39
|
Human papillomavirus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinoma.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.93
|
|
40
|
Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypes.
|
J Pediatr
|
2011
|
0.93
|
|
41
|
Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers.
|
Int J Cancer
|
2008
|
0.92
|
|
42
|
Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
|
Int J Cancer
|
2014
|
0.92
|
|
43
|
Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients.
|
Pathol Oncol Res
|
2011
|
0.91
|
|
44
|
Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort.
|
Int J Cancer
|
2014
|
0.89
|
|
45
|
Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
|
Cancer Causes Control
|
2014
|
0.89
|
|
46
|
Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study.
|
Int J Cancer
|
2013
|
0.89
|
|
47
|
Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study.
|
Int J Cancer
|
2013
|
0.89
|
|
48
|
Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.
|
BMC Infect Dis
|
2014
|
0.87
|
|
49
|
Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.
|
Mol Ther
|
2010
|
0.87
|
|
50
|
Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses.
|
J Virol
|
2009
|
0.87
|
|
51
|
Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin.
|
J Invest Dermatol
|
2013
|
0.87
|
|
52
|
Prevalence and stability of antibodies to 37 human papillomavirus types--a population-based longitudinal study.
|
Virology
|
2010
|
0.87
|
|
53
|
Longitudinal study of seroprevalence and serostability of the human polyomaviruses JCV and BKV in organ transplant recipients.
|
J Med Virol
|
2012
|
0.86
|
|
54
|
Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.
|
J Infect Dis
|
2010
|
0.86
|
|
55
|
Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: a population-based study in Amsterdam.
|
Sex Transm Dis
|
2010
|
0.86
|
|
56
|
Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients.
|
Int J Cancer
|
2014
|
0.84
|
|
57
|
Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin.
|
J Infect Dis
|
2012
|
0.84
|
|
58
|
Route of sexual exposure is independently associated with seropositivity to HPV-16 and HPV-18 among clients of an STI clinic in the Netherlands.
|
J Infect Dis
|
2013
|
0.83
|
|
59
|
A case-control study of cutaneous squamous cell carcinoma among Caucasian organ transplant recipients: the role of antibodies against human papillomavirus and other risk factors.
|
Int J Cancer
|
2009
|
0.83
|
|
60
|
The Association between cutaneous squamous cell carcinoma and betapapillomavirus seropositivity: a cohort study.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.83
|
|
61
|
Genome-wide association study of HPV seropositivity.
|
Hum Mol Genet
|
2011
|
0.82
|
|
62
|
The HPV16 transcriptome in cervical lesions of different grades.
|
Mol Cell Probes
|
2011
|
0.81
|
|
63
|
Serological markers for papillomavirus infection and skin tumour development in the rodent model Mastomys coucha.
|
J Gen Virol
|
2010
|
0.81
|
|
64
|
Prevalence, incidence, and risk factors for human papillomavirus 16 seropositivity in Australian homosexual men.
|
Sex Transm Dis
|
2012
|
0.81
|
|
65
|
Obesity and head and neck cancer risk and survival by human papillomavirus serology.
|
Cancer Causes Control
|
2014
|
0.81
|
|
66
|
No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: Minnesota Cancer Prevention Research Unit Polyp Study.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.81
|
|
67
|
Seroreactivity of 38 human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls.
|
J Invest Dermatol
|
2009
|
0.81
|
|
68
|
Prospective study of genital human papillomaviruses and nonmelanoma skin cancer.
|
Int J Cancer
|
2013
|
0.80
|
|
69
|
Human papillomavirus infection among 100 oesophageal cancer cases in the People's Republic of China.
|
Int J Cancer
|
2007
|
0.78
|
|
70
|
Viral infections and colorectal cancer: a systematic review of epidemiological studies.
|
Int J Cancer
|
2014
|
0.78
|
|
71
|
Longitudinal study of seroprevalence and serostability of 34 human papillomavirus types in European organ transplant recipients.
|
Virology
|
2012
|
0.78
|
|
72
|
Lack of association between the presence and persistence of betapapillomavirus DNA in eyebrow hairs and betapapillomavirus L1 antibodies in serum.
|
J Gen Virol
|
2010
|
0.78
|
|
73
|
The seroprevalence of human papillomavirus by immune status and by ethnicity in London.
|
Infect Agent Cancer
|
2009
|
0.77
|
|
74
|
Human papillomavirus types 6 and 11 seropositivity: risk factors and association with ano-genital warts among homosexual men.
|
J Infect
|
2013
|
0.77
|
|
75
|
The Natural History of Human Polyomaviruses and Herpesviruses in Early Life-The Rhea Birth Cohort in Greece.
|
Am J Epidemiol
|
2016
|
0.76
|
|
76
|
A capture ELISA for monitoring papillomavirus-induced antibodies in Mastomys coucha.
|
J Virol Methods
|
2009
|
0.76
|
|
77
|
Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics.
|
Med Microbiol Immunol
|
2015
|
0.76
|
|
78
|
The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK.
|
Infect Agent Cancer
|
2009
|
0.75
|
|
79
|
Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.
|
PLoS One
|
2016
|
0.75
|
|
80
|
HIV is an important risk factor for human papillomavirus types 16 and 18 seropositivity among sexually active men who have sex with men.
|
Sex Transm Dis
|
2015
|
0.75
|
|
81
|
A multiplex method for the detection of serum antibodies against in silico-predicted tumor antigens.
|
Cancer Immunol Immunother
|
2014
|
0.75
|
|
82
|
Human papillomavirus antibody response following HAART initiation among MSM.
|
AIDS
|
2017
|
0.75
|
|
83
|
Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.
|
Hum Vaccin Immunother
|
2014
|
0.75
|